文献速递肝病

耐药菌直肠定植增加肝硬化危重患者感染同一菌株的风险

Rectal colonization by resistant bacteria increases the risk of infection by the colonizing strain in critically ill patients with cirrhosis.
PubMed 文献 · J Hepatol · 2022-01-22

该研究评估了肝硬化危重患者直肠耐药菌定植情况及继发感染风险。巴塞罗那队列前瞻性纳入486例危重患者(129例肝硬化,357例无肝硬化),另回顾性分析法兰克福421例肝硬化患者。结果显示肝硬化患者入院时定植率高于无肝硬化者,定植独立增加同一菌株感染风险(肝硬化HR 7.41,无肝硬化HR 5.65)。

要点

  • 肝硬化危重患者直肠耐药菌定植率高达28.7%-47%,且定植独立增加同一菌株感染风险。
  • 巴塞罗那队列中肝硬化患者入院时定植率28.7% vs 无肝硬化18.2%(p=0.01)。
  • 定植菌以产超广谱β-内酰胺酶肠杆菌目为主,法兰克福队列以耐万古霉素肠球菌为主。

核心结论

  • 肝硬化危重患者直肠耐药菌定植极为常见,定植增加感染同一耐药菌株的风险。

研究设计与样本

  • 巴塞罗那队列前瞻性纳入2015-2016年486例连续危重患者(129例肝硬化,357例无肝硬化),入院时及每周直肠拭子检测耐药菌定植。
  • 法兰克福队列回顾性纳入2010-2018年421例肝硬化患者,评估另一流行病学场景下的耐药菌直肠定植。

主要发现

  • 巴塞罗那队列159例(32.7%)定植耐药菌,其中入院时102例(64.2%)、随访期间57例(35.8%)。
  • 肝硬化患者入院时直肠定植率高于无肝硬化患者(28.7% vs 18.2%,p=0.01),ICU住院期间定植率相似。
  • 两组最常见耐药菌均为产超广谱β-内酰胺酶肠杆菌目。
  • 耐药菌定植独立增加入院时及随访期间耐药菌感染风险;肝硬化患者感染定植菌株风险HR 7.41,无肝硬化患者HR 5.65。
  • 法兰克福队列耐药菌定植率47%(198例;入院时131例[66.2%],随访期间67例[33.8%]),最常见为耐万古霉素肠球菌;定植亦与耐药菌感染风险增加相关;耐药菌携带者感染主要由定植菌株引起。

临床怎么用

  • 作者认为定植数据可用于指导肝硬化患者的经验性抗生素治疗和降阶梯策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: It remains unclear whether rectal colonization with multidrug-resistant organisms (MDROs) is prevalent and predisposes to infections by the same pathogens in patients with cirrhosis. METHODS: Two series of critically ill patients were evaluated. In the Barcelona cohort, 486 consecutive patients were prospectively evaluated, 129 with and 357 without cirrhosis (2015-2016). Rectal swabs were performed at admission and weekly thereafter (until intensive care unit [ICU] discharge) to detect MDRO colonization. Risk factors for colonization and infection by MDROs were evaluated. A retrospective cohort from Frankfurt (421 patients with cirrhosis; 2010-2018) was investigated to evaluate MDRO rectal colonization in another epidemiological scenario. RESULTS: In the Barcelona cohort, 159 patients were colonized by MDROs (32.7%), 102 (64.2%) at admission and 57 (35.8%) during follow-up. Patients with cirrhosis showed higher rates of rectal colonization at admission than those without cirrhosis (28.7% vs. 18.2%, p = 0.01) but similar colonization rates during ICU stay. Extended-spectrum beta-lactamase-Enterobacterales were the most frequent MDROs isolated in both groups. Colonization by MDROs independently increased the risk of infection by MDROs at admission and during follow-up. Risk of new infection by the colonizing strain was also significantly increased in patients with (hazard ratio [HR] 7.41) and without (HR 5.65) cirrhosis. Rectal colonization by MDROs was also highly prevalent in Frankfurt (n = 198; 47%; 131 at admission [66.2%] and 67 [33.8%] during follow-up), with vancomycin-resistant enterococci being the most frequent colonizing organism. Rectal colonization by MDROs was also associated with an increased risk of infection by MDROs in this cohort. Infections occurring in MDR carriers were mainly caused by the colonizing strain. CONCLUSION: Rectal colonization by MDROs is extremely frequent in critically ill patients with cirrhosis. Colonization increases the risk of infection by the colonizing resistant strain. LAY SUMMARY: Rectal colonization by multidrug-resistant organisms (MDROs) is a prevalent problem in patients with cirrhosis requiring critical care. The pattern of colonizing bacteria is heterogeneous with relevant differences between centers. Colonization by MDROs is associated with increased risk of infection by the colonizing bacteria in the short term. This finding suggests that colonization data could be used to guide empirical antibiotic therapy and de-escalation policies in patients with cirrhosis.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Prado V, Hernández-Tejero M, Mücke MM, et al. Rectal colonization by resistant bacteria increases the risk of infection by the colonizing strain in critically ill patients with cirrhosis. J Hepatol. 2022. PMID: 35074475. doi:10.1016/j.jhep.2021.12.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。